Evidence map›Paper›PMID 38495883›Full record

ArticleFrontiers in immunology2024

Strain specific differences in vitamin D3 response: impact on gut homeostasis.

Laura Schreiber, Sakhila Ghimire, Andreas Hiergeist, Kathrin Renner, Michael Althammer, Nathalie Babl, Alice Peuker, Gabriele Schoenhammer, Katrin Hippe, Andre Gessner and 10 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 1 country.

Laura Schreiber *Department of Internal Medicine III, Hematology and Medical Oncology, University Hospital Regensburg, Regensburg, Germany.
Sakhila Ghimire *Department of Internal Medicine III, Hematology and Medical Oncology, University Hospital Regensburg, Regensburg, Germany.
Andreas HiergeistInstitute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany.
Kathrin RennerDepartment of Otorhinolaryngology, University Hospital Regensburg, Regensburg, Germany.
Michael AlthammerDepartment of Internal Medicine III, Hematology and Medical Oncology, University Hospital Regensburg, Regensburg, Germany.
Nathalie BablDepartment of Internal Medicine III, Hematology and Medical Oncology, University Hospital Regensburg, Regensburg, Germany.
Alice PeukerDepartment of Internal Medicine III, Hematology and Medical Oncology, University Hospital Regensburg, Regensburg, Germany.
Gabriele SchoenhammerDepartment of Internal Medicine III, Hematology and Medical Oncology, University Hospital Regensburg, Regensburg, Germany.
Katrin HippeDepartment of Pathology, University of Regensburg, Regensburg, Germany.
Andre GessnerInstitute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany.
Christin AlbrechtLeibniz Institute for Immunotherapy (LIT), Regensburg, Germany.
Fransziska PielmeierLeibniz Institute for Immunotherapy (LIT), Regensburg, Germany.
Maike Büttner-HeroldDepartment of Nephropathology, Institute of Pathology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Heiko BrunsDepartment of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Petra HoffmannLeibniz Institute for Immunotherapy (LIT), Regensburg, Germany.
Wolfgang HerrDepartment of Internal Medicine III, Hematology and Medical Oncology, University Hospital Regensburg, Regensburg, Germany.
Ernst HollerDepartment of Internal Medicine III, Hematology and Medical Oncology, University Hospital Regensburg, Regensburg, Germany.
Katrin PeterDepartment of Internal Medicine III, Hematology and Medical Oncology, University Hospital Regensburg, Regensburg, Germany.
Marina KreutzDepartment of Internal Medicine III, Hematology and Medical Oncology, University Hospital Regensburg, Regensburg, Germany.
Carina MatosDepartment of Internal Medicine III, Hematology and Medical Oncology, University Hospital Regensburg, Regensburg, Germany.
University Hospital Regensburg · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DELeibniz Institute for ImmunotherapyLeibniz Association · DEUniversity of Regensburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vitamin D3 regulates a variety of biological processes irrespective of its well-known importance for calcium metabolism. Epidemiological and animal studies indicate a role in immune regulation, intestinal barrier function and microbiome diversity. Here, we analyzed the impact of different vitamin D3- containing diets on C57BL/6 and BALB/c mice, with a particular focus on gut homeostasis and also investigated effects on immune cells

Indexed as

CholecalciferolIntestine, SmallAnimalsDietEpithelial CellsMiceMice, Inbred C57BLCholecalciferolBALB/cbarrier functionC57BL/6intestinalvitamin D3

Identifiers

PMID38495883
PMCPMC10943696
OpenAlexW4392365176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.